Domínguez-Paredes Ana Luisa, Varela-Tapia Clara Lilia, Dorado-Arias Valeska, Salazar-Núñez Elizabeth, Martínez-Barro Daniel
Instituto Mexicano del Seguro Social, Unidad Médica de Alta Especialidad Traumatología, Ortopedia y Rehabilitación, "Dr. Victorio de la Fuente Narváez", Unidad de Medicina Física y Rehabilitación Norte, Servicio de Rehabilitación Cardiopulmonar. Ciudad de México, México.
Instituto Mexicano del Seguro Social, Unidad Médica de Alta Especialidad Traumatología, Ortopedia y Rehabilitación, "Dr. Victorio de la Fuente Narváez", Unidad de Medicina Física y Rehabilitación Norte, Servicio de Psicología. Ciudad de México, México.
Rev Med Inst Mex Seguro Soc. 2023 Nov 6;61(6):796-801. doi: 10.5281/zenodo.10064351.
COVID-19 is associated with multiple complications, in addition to those produced at the pulmonary level. Post-COVID-19 cognitive deficits have been detected in the cognitive domain of attention and executive functions, even 4 months after COVID-19.
to determine the frequency of cognitive alterations in patients recovered from COVID-19.
A cross-sectional, descriptive and analytical study was carried out. Records of patients in care after infection by SARS-CoV-2 were integrated, the Neuropsi test was applied. Descriptive statistics and association tests were used through the Chi square test, taking p < 0.05 as significant.
Data from 44 files were integrated. The median age, I place them in the sixth decade of life. There was a predominance of men (63.6%). The most frequent comorbidities were systemic arterial hypertension (50%) and diabetes mellitus (40.9%). Most of the patients were managed only at home (61.4%) with a moderate-severe COVID-19 picture (68.2%). The most affected dimensions of the Neuropsi test were attention and concentration (47.7%, mild alteration) and short-term memory (77.3%, mild alteration).
Cognitive impairment in patients recovered from COVID-19 assessed through the Neuropsi test presented mild alterations in attention and concentration, as well as in short-term memory. These could affect functionality, quality of life and ability to perform work.
新型冠状病毒肺炎（COVID-19）除了会引发肺部并发症外，还与多种其他并发症相关。即使在感染COVID-19四个月后，也已在注意力和执行功能等认知领域检测到COVID-19后认知缺陷。
确定COVID-19康复患者认知改变的频率。
开展了一项横断面、描述性和分析性研究。整合了感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）后接受护理的患者记录，并应用了神经心理测试。通过卡方检验进行描述性统计和关联测试，以p<0.05为有统计学意义。
整合了44份档案的数据。年龄中位数处于第六个十年。男性占主导（63.6%）。最常见的合并症是系统性动脉高血压（50%）和糖尿病（40.9%）。大多数患者仅在家中接受治疗（61.4%），呈现中度至重度COVID-19症状（68.2%）。神经心理测试中受影响最严重的维度是注意力和专注力（47.7%，轻度改变）以及短期记忆（77.3%，轻度改变）。
通过神经心理测试评估，COVID-19康复患者的认知障碍在注意力、专注力以及短期记忆方面呈现轻度改变。这些改变可能会影响功能、生活质量和工作能力。
